Literature DB >> 1730899

J774 macrophages secrete antibiotics via organic anion transporters.

C X Cao1, S C Silverstein, H C Neu, T H Steinberg.   

Abstract

Mouse macrophages and J774 macrophage-like cells express probenecid-inhibitable organic anion transporters that remove anionic dyes from the cells' cytoplasmic matrix and secrete these dyes into the extracellular medium. The present studies show that these transporters also secrete antibiotics from J774 macrophages. Penicillin G permeates J774 cells poorly, but after it was introduced into the cell cytoplasm, it was secreted in a probenecid-inhibitable fashion. The quinolone norfloxacin enters macrophages readily. Probenecid retarded the secretion of intracellular norfloxacin by J774 cells and enhanced norfloxacin accumulation three- to fourfold. Thus the intracellular accumulation of norfloxacin is regulated in part by organic anion transporters that secrete norfloxacin (and penicillin G) from J774 cells. This transport process may have clinical significance, as fluoroquinolones inhibit growth of intracellular pathogens such as mycobacteria and Brucella organisms in vitro but fail to arrest infections with these organisms in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730899     DOI: 10.1093/infdis/165.2.322

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter.

Authors:  Y K Oh; R M Straubinger
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  Entry and intracellular survival of group B streptococci in J774 macrophages.

Authors:  P Valentin-Weigand; P Benkel; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 4.  Management of listeriosis.

Authors:  H Hof; T Nichterlein; M Kretschmar
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Drug effects on intracellular mycobacteria determined by mass spectrometric analysis of the Na(+)-to-K+ ratios of individual bacterial organisms.

Authors:  M Wiese; U Seydel
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 6.  Intracellular concentrations of antibacterial agents and related clinical implications.

Authors:  J D Butts
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

7.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Effect of thioridazine on experimental cutaneous staphylococcal infections.

Authors:  Beth L Hahn; Peter G Sohnle
Journal:  In Vivo       Date:  2014 Jan-Feb       Impact factor: 2.155

9.  Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.

Authors:  Ann Lismond; Paul M Tulkens; Marie-Paule Mingeot-Leclercq; Patrice Courvalin; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

10.  Lipopolysaccharide increases the expression of multidrug resistance-associated protein 1 (MRP1) in RAW 264.7 macrophages.

Authors:  Peter S Silverstein; Kenneth L Audus; Nilofer Qureshi; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.